Research Paper Volume 14, Issue 5 pp 2320—2334

Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma

class="figure-viewer-img"

Figure 1. Expression levels of PLKs in TCGA and CGGA databases. (A) Expression levels of PLKs in patients with GBM. (B) Gene Expression Profile shows the expression of PLKs between GBM (red) and normal tissue (green) via GEPIA2. (C) Box plot shows the expression of PLKs between brain tumor (red) and normal tissue (grey) via GEPIA2. The “*” indicates that the p-value is statistically significant. (D) Box plot shows the expression of PLKs in different WHO classes via CGGA database.